<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27014" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neurolytic Procedures</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ben Aziz</surname>
            <given-names>Mohammed</given-names>
          </name>
          <aff>ULB: Institut Jules Bordet (cancer research)</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cascella</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Via Mariano Semmola 80100, Napoli. Italy</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohammed Ben Aziz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Cascella declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27014.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Severe intractable oncogenic pain, often resulting from nerve damage due to cancer, trauma, or other medical conditions such as diabetes and infections, can lead to debilitating peripheral nerve neuralgia or peripheral neuropathic pain. When pharmacological treatments fail to provide sufficient relief and negatively impact the quality of life, non-pharmacological options like peripheral neurolytic blocks become essential. Neurolytic blocks, which disrupt nerve signals, are especially beneficial for managing pain that is unresponsive to medication. However, a thorough preoperative assessment is critical to ensure the patient's prognosis and overall health are suitable for the procedure, minimizing risks and optimizing benefits.</p>
        <p>In this course, participants gain expertise in evaluating and managing severe intractable peripheral nerve pain, focusing on pharmacological and non-pharmacological treatments, including neurolytic blocks. The course emphasizes the importance of interprofessional collaboration, where pain specialists, neurologists, anesthesiologists, and other healthcare professionals work together to develop individualized treatment plans. This team-based approach ensures comprehensive care, improving diagnostic accuracy, optimizing pain management strategies, and enhancing overall patient outcomes by addressing the complexities of chronic pain in a coordinated manner.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Screen patients with severe pain for potential suitability of neurolytic block therapy based on clinical presentation and prognosis.</p></list-item><list-item><p>Differentiate between pharmacological and non-pharmacological treatment options, including the use of neurolytic blocks.</p></list-item><list-item><p>Assess the risks and benefits of neurolytic blocks for individual patients through thorough preoperative evaluation.</p></list-item><list-item><p>Highlight the significance of collaboration and communication among the interprofessional team to enhance the efficacy of peripheral neurolytic blocks and to improve patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27014&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27014">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27014.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Peripheral nerve neuralgia or peripheral neuropathic pain may result from damage of a nerve due to various etiologies, including medical conditions such as diabetes, infections (eg, postherpetic neuralgia), kidney diseases, or nerve compressions such as entrapment, peripheral nerve injury due to trauma, cancer, or a combination of the above. Although treatment strategies for neuralgia usually start with pharmacotherapy with medications such as membrane-stabilizing agents (eg, gabapentin or pregabalin), anticonvulsants (eg, carbamazepine, topiramate, and lamotrigine), antidepressants (eg, amitriptyline), and muscle relaxants (eg, baclofen) to reduce the excitability of the peripheral nerve and central connections,<xref ref-type="bibr" rid="article-27014.r1">[1]</xref>&#x000a0;drug treatment often fails to obtain effective results and can expose the patient to adverse events with poor improvement in the quality of life. Therefore, it is often necessary to resort to nonpharmacological strategies such as neurolytic blocks. These approaches, however, are not only applicable when pharmacological strategies have failed but are to be integrated into the context of multimodal schemes.<xref ref-type="bibr" rid="article-27014.r2">[2]</xref>&#x000a0;Moreover, some types of painful conditions, such as pain from pancreatic neoplasia, require the early application of minimally invasive analgesic techniques to manage symptoms effectively.<xref ref-type="bibr" rid="article-27014.r3">[3]</xref>&#x000a0;</p>
        <p>A neurolytic block involves the deliberate injury of a nerve by freezing, heating, or applying chemicals to cause a temporary degeneration of targeted nerve fibers, causing an interruption in the signal nerve transmission. In particular, neurolysis implies the destruction of neurons by placing a needle close to the nerve and either injecting neurodestructive chemical agents or producing damage with a physical method such as cold (ie, cryotherapy) or heat (ie, radiofrequency ablation).</p>
        <p>Neurolytic blocks can be seen as a natural advancement from neurotomy. Neurotomy involves the transection or partial resection of a nerve, typically performed on small peripheral nerves that are exclusively sensory. This technique has historically been applied for treating conditions such as trigeminal neuralgia and pelvic pain syndrome (presacral neurotomy), as well as nonpainful conditions like spastic dysfunction of the elbow. However, as the surgical cutting of a nerve may lead to complications such as painful neuromas or differentiation over time, neurolytic approaches are generally preferred over surgical ones.</p>
        <p>Neurolytic blocks are not a recent discovery. The first report of chemical neurolysis for treating pain was made in 1863 by Luton, who administered neurolytic agents into painful areas. Neural blockade with neurolytic agents has been documented for treating pain for over a century. In 1904, Schloesser was the first to report alcohol neurolysis for treating trigeminal neuralgia.<xref ref-type="bibr" rid="article-27014.r4">[4]</xref>&#x000a0;In 1928, Doppler used phenol neurolysis to destroy presacral sympathetic nerves for the treatment of pelvic pain.</p>
        <p>Currently, the specialty of pain medicine defines neurolysis as the selective, iatrogenic destruction of neural tissue aimed at alleviating pain. As understanding of nervous system pathophysiology has deepened and techniques and tools have been refined, the applications for these techniques have expanded. For instance, advances in medical imaging have enhanced the precision and efficacy of interventional pain management. As a result, using peripheral neural blockade and neuro-destructive techniques has increased for the treatment of chronic intractable pain.<xref ref-type="bibr" rid="article-27014.r5">[5]</xref>&#x000a0;Additionally, peripheral nerve blockade is now recognized as a valuable treatment for muscle spasticity.<xref ref-type="bibr" rid="article-27014.r6">[6]</xref></p>
      </sec>
      <sec id="article-27014.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Chemical and surgical neurolysis can have serious adverse events, so a thorough knowledge of the relevant anatomy and the mechanisms by which the neurolytic agent destroys nerve tissue is essential. The choice of anatomy for neurolysis depends on the sensory territory intended for the blockade. Common targets include peripheral nerves, sympathetic ganglia, and dorsal roots. The neurolytic blockade is typically guided by techniques such as ultrasonography, fluoroscopy, or nerve stimulation. Before proceeding with a neurolytic block, performing a diagnostic block using a local anesthetic is critical to assess the correct location of the intended neurolysis. Successful application of a neurolytic block requires a strong understanding of anatomy, meticulous management of potential side effects, and selecting appropriate block techniques.<xref ref-type="bibr" rid="article-27014.r7">[7]</xref></p>
      </sec>
      <sec id="article-27014.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Proper selection of patients for neurolytic blocks is the key to the success of these potentially harmful procedures. Clear communication of alternative techniques, outcomes, complications, expectations, and disease progression with the patient and the family is important before a neurolytic procedure. An interprofessional approach, including an aggressive trial of opioids and adjuvant medications, along with temporary nerve blocks and psychological support, are the mainstays of therapy. A thorough medical examination, including laboratory testing and imaging studies, if appropriate, is necessary before performing this procedure. Neurolytic blocks are also valuable for differential diagnosis, as they help pinpoint the location and cause of pain and assess the patient's response to pain relief. When properly administered, these blocks can be used to predict the outcomes of sustained interruption, whether through the injection of neurolytic agents or neurosurgical transection.</p>
        <p><bold>Upper abdominal malignancies or chronic pancreatitis:</bold> Patients with intractable pain due to upper abdominal malignancies or chronic pancreatitis often experience a significant decrease in quality of life and may require high doses of opioids, leading to severe adverse events.<xref ref-type="bibr" rid="article-27014.r8">[8]</xref>&#x000a0;The percutaneous neurolytic celiac plexus block (NCPB) has been shown to reduce narcotic use by 70% to 90% in these patients.<xref ref-type="bibr" rid="article-27014.r9">[9]</xref>&#x000a0;Results from a meta-analysis covering 24 studies reported good to excellent pain relief in 89% of patients within the first 2 weeks after NCPB, with benefits persisting beyond 3 months.<xref ref-type="bibr" rid="article-27014.r10">[10]</xref></p>
        <p><bold>Trigeminal neuralgia:</bold> One of the most common forms of craniofacial pain, trigeminal neuralgia is characterized by sudden, brief, and excruciating facial pain attacks in 1 or more branches of the trigeminal nerve.<xref ref-type="bibr" rid="article-27014.r11">[11]</xref>&#x000a0;This pain may lead to a severe reduction in the quality of life of affected patients. Internal neurolysis is an effective surgical treatment for trigeminal neuralgia without neurovascular compression.<xref ref-type="bibr" rid="article-27014.r12">[12]</xref></p>
        <p><bold>Chest wall pain:</bold> Intercostal nerve block by chemical neurolysis with phenol shows promise as a therapeutic option in patients with intractable cancer-associated chest wall pain or postsurgical thoracic pain.<xref ref-type="bibr" rid="article-27014.r13">[13]</xref></p>
        <p><bold>Pelvic cancer pain:</bold> Pain associated with pelvic malignancies can be treated by superior hypogastric plexus blockade or neurolysis.<xref ref-type="bibr" rid="article-27014.r14">[14]</xref>&#x000a0;</p>
        <p><bold>Facetogenic and vertebral pain: </bold>Pain originating from the facet joints and vertebrae may be effectively managed with neurolysis of the medial branch of the primary dorsal ramus. This technique specifically targets the nerves supplying these structures, offering significant pain relief.<xref ref-type="bibr" rid="article-27014.r15">[15]</xref>&#x000a0;</p>
        <p><bold>Other indications:</bold> Ultrasound-guided alcohol ablation has been described to treat Morton neuroma, and several studies have been performed describing the safety and efficacy of alcohol ablation in these cases.<xref ref-type="bibr" rid="article-27014.r16">[16]</xref>&#x000a0;Additionally, alcohol neurolysis of the lateral femoral cutaneous nerve has been described to treat meralgia paresthetica.<xref ref-type="bibr" rid="article-27014.r17">[17]</xref></p>
      </sec>
      <sec id="article-27014.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Absolute contraindications to a peripheral nerve blockade are rare. They include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patient refusal</p>
          </list-item>
          <list-item>
            <p>Skin infection over the intended catheter or needle site</p>
          </list-item>
          <list-item>
            <p>Allergy to a chemical neurolytic agent</p>
          </list-item>
        </list>
        <p>Relative contraindications include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Coagulopathy:</bold> Oral anticoagulants should be discontinued until the international normalized ratio is reduced to 1.5 or less. Correcting coagulopathy is especially important if the injection is planned at a site that cannot be easily compressed to control bleeding.</p>
          </list-item>
          <list-item>
            <p><bold>Electronic implants:</bold> Patients with pacemakers or other electronic implants must be evaluated before procedures like radiofrequency ablation to prevent device interference or malfunction.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27014.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The following equipment is necessary to perform a peripheral nerve blockade:</p>
        <p><bold>Antiseptic agents:</bold> Chlorhexidine gluconate or povidone-iodine for skin preparation</p>
        <p><bold>Guidance equipment:</bold>&#x000a0;Based on the procedural type, an ultrasound probe with a sterile cover and gel, fluoroscopy equipment, and a nerve stimulator should be used as needed.</p>
        <p><bold>Injection tools</bold>:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Local anesthetics: </bold>One pecent&#x000a0;lidocaine for local anesthesia and 2% lidocaine or 1.5% mepivacaine for diagnostic blocks</p>
          </list-item>
          <list-item>
            <p><bold>Syringes and needles:</bold>&#x000a0;Ten to 20 mL syringe with extension tubing; block needles variable in length depending on the depth and location of the targeted nerve or spinal/epidural needles if a neuraxial approach is used.</p>
          </list-item>
          <list-item>
            <p><bold>Chemical neurolytic agents:</bold> Includes 50% to 100% alcohol, 5% to 15% phenol, and other agents like hypertonic saline, glycerol, ammonium salt solutions, and chlorocresol.<xref ref-type="bibr" rid="article-27014.r18">[18]</xref></p>
          </list-item>
        </list>
        <p><bold>Ablation devices</bold>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Radiofrequency probes for nerve ablation procedures such as medial branch nerve ablation, percutaneous cordotomy, and thermocoagulation</p>
          </list-item>
          <list-item>
            <p>Cryomachines and cryoprobes with cooling agents like nitrous oxide or carbon dioxide are used for cryotherapy.</p>
          </list-item>
        </list>
        <p><bold>Monitoring equipment: </bold>Basic monitoring tools, including electrocardiogram, noninvasive blood pressure monitoring, pulse oximetry, and end-tidal carbon dioxide monitoring, are essential throughout the procedure.</p>
      </sec>
      <sec id="article-27014.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Neurolytic blocks should be performed in specialized interventional pain procedure rooms staffed by pain medicine specialists trained in ultrasound- and fluoroscopic-guided nerve injections. Additionally, trained nursing staff skilled in sedation anesthesia should be available to assist during the procedures.</p>
      </sec>
      <sec id="article-27014.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Patient preparation must be carried out considering that the procedure, although well-tolerated and safe in most cases, can still lead to serious complications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Informed consent is mandatory before conducting the intervention. The consent must contain details of the procedure and possible complications (possibly with frequency).</p>
          </list-item>
          <list-item>
            <p>An intravenous line should be placed.</p>
          </list-item>
          <list-item>
            <p>Aseptic technique should be maintained throughout the procedure.</p>
          </list-item>
          <list-item>
            <p>The position of the patient depends on the procedure to be performed.</p>
          </list-item>
          <list-item>
            <p>Sedation may be necessary for certain painful acts, such as chemical neurolysis. Although, excessive sedation of the patient should be avoided to allow patients to remain alert enough to report symptoms suggestive of any complication.<xref ref-type="bibr" rid="article-27014.r19">[19]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27014.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Neurolysis procedures generally follow a 3-phase approach:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Preparation and initial identification:</bold> Under aseptic conditions and continuous cardiovascular monitoring, the target nerve is identified using ultrasound, nerve stimulation, or fluoroscopy. A local anesthetic is then administered to the skin and subcutaneous tissues over the target area to minimize patient discomfort during the procedure.</p>
          </list-item>
          <list-item>
            <p><bold>Diagnostic and confirmatory phase:</bold> A needle attached to a radiofrequency probe or cryoprobe is advanced toward the identified nerve. A diagnostic block using a local anesthetic is performed to confirm the correct targeting of the nerve.</p>
          </list-item>
          <list-item>
            <p><bold>Execution of neurolysis:</bold> Once the diagnostic block is confirmed, the neurolysis procedure is carried out.&#x000a0;In the case of radiofrequency ablation (RFA), a&#x000a0;microelectrode is inserted through the needle to begin the neurolysis. If chemical neurolysis is to be performed, the prepared chemical solution, like phenol, is injected. Because phenol has immediate local anesthetic effects, injection is typically painless.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Neurolysis Procedure Types</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold><bold>Chemical neurolysis</bold>
</bold>utilizes both nonselective agents and neuroselective toxins to manage pain. Nonselective agents such as phenol, ethyl alcohol, and glycerol 50% work by causing protein denaturation and Wallerian degeneration, which provide long-lasting analgesia typically lasting between 3 to 6 months.<xref ref-type="bibr" rid="article-27014.r20">[20]</xref> These agents act by nonselectively denaturing proteins, which results in the loss of cellular contents and leads to structural disruption of the nerve. On the other hand, neuroselective toxins target specific nerve functions to alleviate pain. Capsaicin, a selective agonist for the transient receptor potential 1 receptor on unmyelinated C fiber nociceptors, induces desensitization by triggering an influx of calcium and sodium ions.<xref ref-type="bibr" rid="article-27014.r21">[21]</xref> Similarly, botulinum toxins impede the release of neurotransmitters such as substance P, calctonin gene-related peptide, and glutamate, which effectively diminishes pain signaling.<xref ref-type="bibr" rid="article-27014.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Cryoneurotomy</bold> uses nitrogen or argon gas to generate extreme cold, selectively destroying diseased tissue while maintaining the structural integrity of the nerve.<xref ref-type="bibr" rid="article-27014.r23">[23]</xref>&#x000a0;Unlike surgical neurectomy, which amputates part of the nerve and often results in severe dysaesthetia, cryoneurotomy offers sustainable pain control, typically without permanent damage to the nerve structure.<xref ref-type="bibr" rid="article-27014.r24">[24]</xref><xref ref-type="bibr" rid="article-27014.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Radiofrequency ablation</bold>&#x000a0;encompasses various treatment methods that target nerve tissue to treat pain and other conditions. RFA uses medium-frequency alternating current to heat small areas of nerve tissue, effectively reducing pain transmission. This versatile technique is not only used for pain relief but also for treating conditions such as cardiac arrhythmias and tumors, and is used in cosmetic dermatology. The effectiveness of RFA largely depends on the application site, with over two-thirds of patients typically experiencing good results. While pain relief generally lasts less than 12 months, some patients report relief lasting several years.<xref ref-type="bibr" rid="article-27014.r26">[26]</xref> Pulsed Radiofrequency, which delivers energy in short pulses to minimize heat production, is particularly effective for managing chronic neuropathic pain.<xref ref-type="bibr" rid="article-27014.r27">[27]</xref><xref ref-type="bibr" rid="article-27014.r28">[28]</xref> Additionally, cooled radiofrequency ablation incorporates active cooling to prevent excessive heat, thereby allowing for larger and more controlled lesions, enhancing its effectiveness and safety.</p>
          </list-item>
          <list-item>
            <p><bold>Laser neurolysis, </bold>documented by Weintraub in 1997, focuses energy on specific nerve points. Laser neurolysis has been shown to alleviate symptoms in conditions like carpal tunnel syndrome and has a high rate of symptom resolution.</p>
          </list-item>
          <list-item>
            <p><bold>Surgical neurolysis or neurectomy&#x000a0;</bold>involves the direct severing of the nerve and is used sparingly. Neurectomy is generally reserved for severe cases due to the high risk of deafferentation pain, which can be more intense than the original symptoms being treated.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27014.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The following are potential complications following a peripheral nerve block:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Infection:</bold> At the injection site</p>
          </list-item>
          <list-item>
            <p><bold>Increased symptoms:</bold> Inflammation and pain may increase at the injection site</p>
          </list-item>
          <list-item>
            <p><bold>Bleeding and bruising:</bold> Due to injury to blood vessels</p>
          </list-item>
          <list-item>
            <p><bold>Nerve damage:</bold> Potential nerve injury
<list list-type="bullet"><list-item><p>Nerve injury can lead to neuritis, dysesthesia, or hyperesthesia, which may cause symptoms like tingling or increased sensitivity. Partial nerve destruction might result in procedural failure.<xref ref-type="bibr" rid="article-27014.r29">[29]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Allergic reactions:</bold>&#x000a0;Local anesthetic or neurolytic medications</p>
          </list-item>
          <list-item>
            <p><bold>Intravascular medication injection:</bold>
<list list-type="bullet"><list-item><p><bold>Phenol:</bold>&#x000a0;This may cause systemic effects such as tinnitus and flushing.</p></list-item><list-item><p><bold>Local anesthetic systemic toxicity:</bold> Initial symptoms often include nausea, vomiting, tinnitus, perioral numbness, and a metallic taste in the mouth. The central nervous system (CNS) is initially stimulated, leading to seizures, then CNS depression and coma. Additionally, toxic levels of local anesthetics can induce cardiac arrhythmias, which may escalate to cardiac arrest.</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27014.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Neurolysis offers patients an alternative way to manage their pain with reduced reliance on systemic medications, significantly improving their quality of life. Neurolysis is primarily advocated for treating severe, intractable malignant pain, typically in cases of advanced terminal cancer. While it is less common, neurolysis can also address certain nonmalignant pain conditions, such as intractable postherpetic neuralgia and chronic pancreatitis. However, the use of these non-pharmacological approaches in managing chronic nonmalignant pain remains controversial and is often discouraged. The literature currently includes large-scale controlled studies on the use and beneficial effects of peripheral neurolytic block in the treatment of malignant and nonmalignant pain. These investigations include randomized controlled trials (RCTs), observational trials, and many case series.</p>
        <p>To evaluate the efficacy of cryoneurolysis in reducing pain associated with knee osteoarthritis, a randomized, double-blind, sham-controlled, multicenter trial was conducted. The study followed patients over 6 months, focusing on those who received cryoneurolysis targeting the infrapatellar branch of the saphenous nerve. Results showed a statistically significant improvement in the WOMAC (Western Ontario and McMaster Osteoarthritis Index) pain subscale scores at 30, 60, and 90 days post-treatment compared to the sham group.<xref ref-type="bibr" rid="article-27014.r30">[30]</xref> Cryoneurolysis led to notable decreases in knee pain and enhanced symptom management for up to 150 days, proving safe and well-tolerated. Notably, the effects of cryoneurolysis are not permanent as cryoinjured axons typically regenerate, with the median duration of pain relief lasting from 2 weeks to 5 months. This makes cryoneurolysis particularly suitable for conditions requiring short- to medium-term analgesia, such as neuroma, entrapment neuropathies, and postoperative pain.<xref ref-type="bibr" rid="article-27014.r31">[31]</xref></p>
        <p>Radiofrequency ablation for the lumbar medial branch has been extensively studied as a treatment for chronic low back pain (LBP). A notable study involving 85 patients with zygapophyseal joint (z-joint)-mediated LBP provided results showing that 70.6% of participants reported reduced pain after at least 6 months. These findings underscore RFA's effectiveness and durability in managing persistent lumbar z-joint pain.<xref ref-type="bibr" rid="article-27014.r32">[32]</xref> Additionally, a systematic review analyzing 1063 papers, which included 11 sham-controlled RCTs, further supports RFA efficacy. This review encompassed studies on discogenic back pain, lumbar facet joint pain, and sacroiliac joint pain, with the majority demonstrating significant pain relief in lumbar facet and sacroiliac joint treatments.<xref ref-type="bibr" rid="article-27014.r33">[33]</xref></p>
        <p>The long-term effectiveness of RFA for chronic LBP remains controversial. One RCT involving 681 participants with chronic LBP originating from facet joints, sacroiliac joints, or a combination including intervertebral disks showed that combining radiofrequency denervation with exercise did not significantly reduce pain intensity after 3 months compared to exercise alone.<xref ref-type="bibr" rid="article-27014.r34">[34]</xref> Despite these findings, radiofrequency denervation continues to be a common treatment for chronic facet joint pain resistant to more conservative treatments. A meta-analysis of&#x000a0;7 trials involving 454 patients found that a subgroup who responded well to diagnostic block procedures experienced significant improvements in back pain compared to controls.<xref ref-type="bibr" rid="article-27014.r35">[35]</xref> However, this effectiveness is debated. Results from a Cochrane analysis by Maas et al, which included 23 RCTs with 1309 participants, found no high-quality evidence that RF denervation provides substantial pain relief in patients with chronic LBP who responded positively to a diagnostic block or discography.<xref ref-type="bibr" rid="article-27014.r36">[36]</xref></p>
        <p>Endoscopic ultrasound-guided neurolytic celiac plexus block (NCPB) should be considered as an adjunct to standard pain management for pancreatic cancer, as&#x000a0;NCPB has been shown to reduce pain effectively. Results from a systematic review of 27 RCTs demonstrated that NCPB not only improves analgesia but also decreases opioid consumption and mitigates opioid-induced adverse effects, compared to conventional analgesic treatments.<xref ref-type="bibr" rid="article-27014.r37">[37]</xref> Although the evidence is robust regarding its analgesic efficacy, the data on reducing opioid consumption and side effects are less conclusive. Nonetheless, current research largely supports the use of NCPB; this procedure is more effective than standard pharmacotherapy in reducing pain, lowering opioid requirements, and consequently, preventing a decline in the quality of life for patients.</p>
        <p>Of all peripheral nerve neurectomies, ilioinguinal and iliohypogastric neurectomies are the most extensively studied. Inguinal neurectomy at the time of hernia repair may reduce the risk of postoperative pain. Results from a meta-analysis (11 studies on 1031 patients, including Lichtenstein hernia repair) showed a significant reduction in pain with neurectomy for short and midterm.<xref ref-type="bibr" rid="article-27014.r38">[38]</xref></p>
        <p>Interventional techniques for managing pain can be highly effective for patients who are unable to tolerate systemic opioids or those with limited life expectancy and localized pain. However, outcomes data for pain relief are inconsistent, primarily due to variations in patient prognosis. Therefore, carefully selecting patients, considering their specific pain location and prognosis, is essential. Moreover, choosing the appropriate interventional technique requires a depth of knowledge that is still developing among clinicians. Peripheral neurolytic blocks are generally recommended only after other treatment modalities&#x02014;including pharmacologic, physical, psychiatric, and non-destructive interventional therapies&#x02014;have failed. In particular cases, such as severe pain from pancreatic neoplasia, minimally invasive techniques like NCPB should be considered early in the treatment pathway.</p>
      </sec>
      <sec id="article-27014.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional approach is essential for successful therapy management, especially in complex interventions like neurolytic blocks. The healthcare team should ideally include a pain specialist, an oncologist, a nurse trained in minimally invasive procedures, and an x-ray technologist. Together, they develop a tailored treatment plan that respects the patient's medical and personal needs while ensuring that ethical considerations such as informed consent and patient autonomy are prioritized.</p>
        <p>The interventional pain specialist assesses pain and plans the block. The oncologist ensures that pain management strategies are compatible with the overall cancer treatment plans. The procedural nurse administers care and monitors the patient during the procedure, while the x-ray technologist guarantees optimal imaging results.</p>
        <p>Effective interprofessional communication is facilitated through regular team meetings and the use of shared electronic health records, maintaining a unified approach to patient care. This coordination is crucial not only for procedural success but also for monitoring patient safety and responding promptly to any adverse events. The patient-centered approach aims to reduce reliance on systemic medications and enhance quality of life.<xref ref-type="bibr" rid="article-27014.r39">[39]</xref>&#x000a0;Ethical practices guarantee that interventions are carried out with the full consent and understanding of the patient. Regular treatment outcomes and team performance reviews are conducted to refine practices and enhance overall patient safety.</p>
      </sec>
      <sec id="article-27014.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27014&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27014">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27014/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27014">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27014.s14">
        <fig id="article-27014.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Celiac Ganglion Block. Performed through posterior access with the patient prone. CT-guided centering system (navigator). The celiac ganglion is found at the front of the Aorta near the emergence of the superior mesenteric artery. The procedure is bilateral. After injection of contrast medium, the procedure is conducted by chemical neurolysis or physical energy. In the photo, the needle is following the path indicated by the navigator to reach the block site. Contributed by Marco Cascella, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Celiac__Ganglion__Block" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27014.s15">
        <title>References</title>
        <ref id="article-27014.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruccu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Truini</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A review of Neuropathic Pain: From Guidelines to Clinical Practice.</article-title>
            <source>Pain Ther</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>Suppl 1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">29178033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cuomo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bimonte</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forte</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Botti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cascella</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Multimodal approaches and tailored therapies for pain management: the trolley analgesic model.</article-title>
            <source>J Pain Res</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>711</fpage>
            <page-range>711-714</page-range>
            <pub-id pub-id-type="pmid">30863143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Reilly</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hasler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pelone</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Callaway</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Capel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Charnley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Corrie</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Elliot</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goodburn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jewell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joharchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McGeeney</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oppong</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Whelan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Primrose</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Neoptolemos</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence.</article-title>
            <source>Pancreatology</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>962</fpage>
            <page-range>962-970</page-range>
            <pub-id pub-id-type="pmid">30292643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cole</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Apfelbaum</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Historical perspectives on the diagnosis and treatment of trigeminal neuralgia.</article-title>
            <source>Neurosurg Focus</source>
            <year>2005</year>
            <month>May</month>
            <day>15</day>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>E4</fpage>
            <pub-id pub-id-type="pmid">15913280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Candido</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Kusper</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Knezevic</surname>
                <given-names>NN</given-names>
              </name>
            </person-group>
            <article-title>New Cancer Pain Treatment Options.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">28265859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pellas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ripart</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>P&#x000e9;lissier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eledjam</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>[Peripheral neurolytic blocks and spasticity].</article-title>
            <source>Ann Fr Anesth Reanim</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>667</fpage>
            <page-range>667-72</page-range>
            <pub-id pub-id-type="pmid">15950114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Superior hypogastric plexus combined with ganglion impar neurolytic blocks for pelvic and/or perineal cancer pain relief.</article-title>
            <source>Pain Physician</source>
            <year>2015</year>
            <season>Jan-Feb</season>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>E49</fpage>
            <page-range>E49-56</page-range>
            <pub-id pub-id-type="pmid">25675070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miceli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bednarova</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rizzardo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cuomo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Riccardi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vetrugno</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bove</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cascella</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Opioids prescriptions in pain therapy and risk of addiction: a one-year survey in Italy. Analysis of national opioids database.</article-title>
            <source>Ann Ist Super Sanita</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>370</fpage>
            <page-range>370-374</page-range>
            <pub-id pub-id-type="pmid">30575575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kambadakone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thabet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gervais</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Arellano</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment.</article-title>
            <source>Radiographics</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>1599</fpage>
            <page-range>1599-621</page-range>
            <pub-id pub-id-type="pmid">21997984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisenberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Chalmers</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis.</article-title>
            <source>Anesth Analg</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>80</volume>
            <issue>2</issue>
            <fpage>290</fpage>
            <page-range>290-5</page-range>
            <pub-id pub-id-type="pmid">7818115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gambeta</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chichorro</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Zamponi</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments.</article-title>
            <source>Mol Pain</source>
            <year>2020</year>
            <season>Jan-Dec</season>
            <volume>16</volume>
            <fpage>1744806920901890</fpage>
            <pub-id pub-id-type="pmid">31908187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Ozpinar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raslan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>McCartney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burchiel</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Long-term efficacy and safety of internal neurolysis for trigeminal neuralgia without neurovascular compression.</article-title>
            <source>J Neurosurg</source>
            <year>2015</year>
            <month>May</month>
            <volume>122</volume>
            <issue>5</issue>
            <fpage>1048</fpage>
            <page-range>1048-57</page-range>
            <pub-id pub-id-type="pmid">25679283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cappellari</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tiberio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alicandro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Spagnoli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grimoldi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Intercostal Neurolysis for The Treatment of Postsurgical Thoracic Pain: a Case Series.</article-title>
            <source>Muscle Nerve</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>671</fpage>
            <page-range>671-675</page-range>
            <pub-id pub-id-type="pmid">29995980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Novy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Felice</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Koyyalagunta</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of Superior Hypogastric Plexus Neurolysis for the Treatment of Cancer-Related Pelvic Pain.</article-title>
            <source>Pain Med</source>
            <year>2020</year>
            <month>Jun</month>
            <day>01</day>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>1255</fpage>
            <page-range>1255-1262</page-range>
            <pub-id pub-id-type="pmid">31343689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Zundert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vanelderen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kessels</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Kleef</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Radiofrequency treatment of facet-related pain: evidence and controversies.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-25</page-range>
            <pub-id pub-id-type="pmid">22090264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasquali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vulcano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Novario</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Varotto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Montoli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Volpe</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound-guided alcohol injection for Morton's neuroma.</article-title>
            <source>Foot Ankle Int</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-9</page-range>
            <pub-id pub-id-type="pmid">25367249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Phui</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Saman</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Alcohol neurolysis of lateral femoral cutaneous nerve for recurrent meralgia paresthetica.</article-title>
            <source>Agri</source>
            <year>2012</year>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-4</page-range>
            <pub-id pub-id-type="pmid">22399128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swerdlow</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Intrathecal neurolysis.</article-title>
            <source>Anaesthesia</source>
            <year>1978</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>8</issue>
            <fpage>733</fpage>
            <page-range>733-40</page-range>
            <pub-id pub-id-type="pmid">581435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Benzoni</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cascella</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Procedural Sedation</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">31869149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Flamer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Supraclavicular Brachial Plexus Neurolysis for a Malignant Peripheral Nerve Sheath Tumor: A Case Report.</article-title>
            <source>A A Pract</source>
            <year>2018</year>
            <month>Dec</month>
            <day>01</day>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>309</fpage>
            <page-range>309-311</page-range>
            <pub-id pub-id-type="pmid">29894352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haanp&#x000e4;&#x000e4;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Treede</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Capsaicin for neuropathic pain: linking traditional medicine and molecular biology.</article-title>
            <source>Eur Neurol</source>
            <year>2012</year>
            <volume>68</volume>
            <issue>5</issue>
            <fpage>264</fpage>
            <page-range>264-75</page-range>
            <pub-id pub-id-type="pmid">23037991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mittal</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Jabbari</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Botulinum Neurotoxins and Cancer-A Review of the Literature.</article-title>
            <source>Toxins (Basel)</source>
            <year>2020</year>
            <month>Jan</month>
            <day>05</day>
            <volume>12</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">31948115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SUNDERLAND</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A classification of peripheral nerve injuries producing loss of function.</article-title>
            <source>Brain</source>
            <year>1951</year>
            <month>Dec</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>491</fpage>
            <page-range>491-516</page-range>
            <pub-id pub-id-type="pmid">14895767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinn</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Repetitive peripheral neurectomies for neurolgia of second and third divisions of trigeminal nerve.</article-title>
            <source>J Oral Surg</source>
            <year>1965</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>7</issue>
            <fpage>600</fpage>
            <page-range>600-8</page-range>
            <pub-id pub-id-type="pmid">5214121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Rozario</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goss</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Effect of peripheral cryoneurotomy and nerve transection on the trigeminal ganglion in rats.</article-title>
            <source>Br J Oral Maxillofac Surg</source>
            <year>2019</year>
            <month>May</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-344</page-range>
            <pub-id pub-id-type="pmid">30952375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r26">
          <label>26</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Shah</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Padalia</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Sphenopalatine Ganglion Radiofrequency Thermocoagulation</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">30725629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sluijter</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Imani</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Evolution and mode of action of pulsed radiofrequency.</article-title>
            <source>Anesth Pain Med</source>
            <year>2013</year>
            <season>Spring</season>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>139</fpage>
            <page-range>139-41</page-range>
            <pub-id pub-id-type="pmid">24223349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cahana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vutskits</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Acute differential modulation of synaptic transmission and cell survival during exposure to pulsed and continuous radiofrequency energy.</article-title>
            <source>J Pain</source>
            <year>2003</year>
            <month>May</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>197</fpage>
            <page-range>197-202</page-range>
            <pub-id pub-id-type="pmid">14622704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r29">
          <label>29</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>D'Souza</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Warner</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <chapter-title>Phenol Nerve Block</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">30247853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radnovich</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dasa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Shrock</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Naranjo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Darr</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Surowitz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Choo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Valadie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harrell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Metyas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cryoneurolysis to treat the pain and symptoms of knee osteoarthritis: a multicenter, randomized, double-blind, sham-controlled trial.</article-title>
            <source>Osteoarthritis Cartilage</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>8</issue>
            <fpage>1247</fpage>
            <page-range>1247-1256</page-range>
            <pub-id pub-id-type="pmid">28336454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilfeld</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Trescot</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound-guided percutaneous cryoneurolysis providing postoperative analgesia lasting many weeks following a single administration: a replacement for continuous peripheral nerve blocks?: a case report.</article-title>
            <source>Korean J Anesthesiol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>567</fpage>
            <page-range>567-570</page-range>
            <pub-id pub-id-type="pmid">29046778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burnham</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Salazar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tate</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Golish</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Teramoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>ZL</given-names>
              </name>
            </person-group>
            <article-title>The Effectiveness of Radiofrequency Ablation of Medial Branch Nerves for Chronic Lumbar Facet Joint Syndrome in Patients Selected by Guideline-Concordant Dual Comparative Medial Branch Blocks.</article-title>
            <source>Pain Med</source>
            <year>2020</year>
            <month>May</month>
            <day>01</day>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>902</fpage>
            <page-range>902-909</page-range>
            <pub-id pub-id-type="pmid">31609391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leggett</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Soril</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Lorenzetti</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Noseworthy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Steadman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tiwana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Clement</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Radiofrequency ablation for chronic low back pain: a systematic review of randomized controlled trials.</article-title>
            <source>Pain Res Manag</source>
            <year>2014</year>
            <season>Sep-Oct</season>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>e146</fpage>
            <page-range>e146-53</page-range>
            <pub-id pub-id-type="pmid">25068973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kapural</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Provenzano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Narouze</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>RE: Juch JNS, et al. Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain: The Mint Randomized Clinical Trials. JAMA 2017;318(1):68-81.</article-title>
            <source>Neuromodulation</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>844</fpage>
            <pub-id pub-id-type="pmid">29220124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of conventional radiofrequency denervation in patients with chronic low back pain originating from the facet joints: a meta-analysis of randomized controlled trials.</article-title>
            <source>Spine J</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>17</volume>
            <issue>11</issue>
            <fpage>1770</fpage>
            <page-range>1770-1780</page-range>
            <pub-id pub-id-type="pmid">28576500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maas</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Ostelo</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Niemisto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jousimaa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hurri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Malmivaara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Tulder</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Radiofrequency denervation for chronic low back pain.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Oct</month>
            <day>23</day>
            <volume>2015</volume>
            <issue>10</issue>
            <fpage>CD008572</fpage>
            <pub-id pub-id-type="pmid">26495910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mercadante</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Klepstad</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kurita</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Sj&#x000f8;gren</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Giarratano</surname>
                <given-names>A</given-names>
              </name>
              <collab>European Palliative Care Research Collaborative (EPCRC)</collab>
            </person-group>
            <article-title>Sympathetic blocks for visceral cancer pain management: A systematic review and EAPC recommendations.</article-title>
            <source>Crit Rev Oncol Hematol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>577</fpage>
            <page-range>577-83</page-range>
            <pub-id pub-id-type="pmid">26297518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barazanchi</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Fagan</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Routine Neurectomy of Inguinal Nerves During Open Onlay Mesh Hernia Repair: A Meta-analysis of Randomized Trials.</article-title>
            <source>Ann Surg</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>264</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-72</page-range>
            <pub-id pub-id-type="pmid">26756767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27014.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cascella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Muzio</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Forte</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cuomo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The underestimated role of psychological and rehabilitation approaches for management of cancer pain. A brief commentary.</article-title>
            <source>Recenti Prog Med</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>107</volume>
            <issue>8</issue>
            <fpage>418</fpage>
            <page-range>418-21</page-range>
            <pub-id pub-id-type="pmid">27571557</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
